The experiments were carried out by W.D., X.L.W. demonstrate that a new generation of anti-influenza computer virus drugs could be developed Cytidine based on selective modulation of MAP kinase pathways to stimulate cell-autonomous immunity. Influenza computer virus is usually a global human and animal respiratory pathogen, causing moderate to severe illness in seasonal outbreaks and periodic world-wide pandemics1,2. Approximately 20% of the world’s populace was infected by influenza computer virus every year, resulting in considerable morbidity and mortality3. Although antiviral drug therapy is essential to reduce disease progression and computer virus transmission, the number and effectiveness of antiviral drugs are limited. Cytidine One of the reasons is the most Cytidine current antiviral drugs directly targeting specific viral proteins4,5. MRK However, the high frequency of RNA computer virus genome mutation leads to current antiviral drugs that are vulnerable to the rapid emergence of viral resistance and frequent evasion of host immune system6,7,8. In addition, genome of influenza computer virus contains eight segmented RNA that encoding a total of eleven proteins (HA, NA, NP, NS1, NS2, PA, M1, M2, PB1-F2, PB1 and PB2), but only NA and M2 have been proved the effective targets for anti-influenza viral therapy9,13. Compared to previous approaches to target viral genome for developing antiviral drugs, recently two novel strategies have been proposed by manipulating cellular factors that are required for the viral life cycle or by stimulating the host antiviral responses10,11,12,13. Host antiviral responses refer to not only immune system activation, but also cellular self-defense. Cellular self-defense also termed as cell-autonomous immunity, is usually developed by all organisms to protect host against microbial pathogens during evolution14,15. Unlike immune cells’ specialized antiviral abilities, cell-autonomous immunity exists in the most cell lineages, providing the first line of host defense16,17. Even before immune system is usually brought on and immune cells are recruited to the location of computer virus contamination, epithelial cells, the initial site of influenza computer virus infection, have already mounted antiviral responses to resist computer virus invasion by preventing entry, uncoating, replication and release at each stage of the viral life cycle, and to restrict computer virus spread through paracrine of cytokines and chemokines rousing the uninfected bystander cells. The effectors of antiviral responses also include constitutive host defense factors18,19,20,21. These mechanisms contribute to efficiently restraining viral replication and spread as well as decreasing tissue damage. Mitogen-activated protein kinase (MAPK) cascades are well known as signal transducers in the conversion of various extracellular signals into cellular response, which regulate numerous genes expression involved in proliferation, differentiation, and also cell death and immune response22,23,24. There are three major members which have been identified to date including extracellular-signal-regulated kinase (ERK), JUN N-terminal kinase (JNK) and p38 kinase, each of them is usually organized in one cascade. Upon influenza computer virus infection, all of three Cytidine pathways are activated25. Recent works have been focused on revealing the functions of p38, JNK and ERK signaling pathways in influenza computer virus life cycle. Several studies showed that p38 and JNK but not ERK have been linked with the expression of cytokines and chemokines, while ERK affected nuclear export of viral ribonucleoprotein complexes (RNPs)26,27,28,29. JNK and p38 are activated in human bronchial epithelial cells upon influenza computer virus contamination. These kinases regulate RANTES expression, which is a part of the innate antiviral response of the cell30,31. If one agent such as the small molecular compound can stimulate host defense factors production in the intracellular pattern or in the pattern of exocytosis, this compound could have an antiviral potential. To test this hypothesis, we used TCID50(50% tissue culture infective dose) method in the influenza A/WSN/33.
